Gilead Sciences (GILD) PT Raised to $87 at Morgan Stanley on 4 Catalysts Driving 2021 Revenue Growth
Tweet Send to a Friend
Morgan Stanley analyst Matthew Harrison raised the price target on Gilead Sciences (NASDAQ: GILD) to $87.00 (from $83.00) after 2021 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
